Cremel Magali, Hamzeh-Cognasse Hind, Genin Christian, Delézay Olivier
Groupe Immunité des Muqueuses et Agents Pathogènes (GIMAP, EA3064), St Etienne University, France.
Vaccine. 2006 Jul 17;24(29-30):5744-54. doi: 10.1016/j.vaccine.2006.04.044. Epub 2006 May 9.
The female genital tract is an important site for numerous pathogens entry. Local immunization, generating specific mucosal IgA and systemic IgG, represents an interesting alternative immunization pathway. However, such a vaccine strategy needs mucosal adjuvants to obtain the best immune response. Considering that the immunization process is mainly dependent on the capture and on the transport of the antigen by Langerhans cells, we evaluated potential adjuvant molecules by analysing their effects on the CCL20 secretion by endocervical and exocervical/vaginal epithelial cells as well as on dendritic cell and Langerhans cell maturation. We demonstrated that DC-Chol and Zymosan are the most efficient mucosal candidate immunoadjuvants that generate a strong increase of CCL20 secretion by the two epithelial cell lines and the maturation of dendritic and Langerhans cells, respectively.
女性生殖道是众多病原体进入的重要部位。局部免疫可产生特异性黏膜IgA和全身性IgG,是一种有趣的替代性免疫途径。然而,这种疫苗策略需要黏膜佐剂以获得最佳免疫反应。鉴于免疫过程主要依赖于朗格汉斯细胞对抗原的捕获和转运,我们通过分析潜在佐剂分子对宫颈内膜和宫颈外/阴道上皮细胞CCL20分泌以及对树突状细胞和朗格汉斯细胞成熟的影响来评估这些分子。我们证明,DC-Chol和酵母聚糖是最有效的黏膜候选免疫佐剂,它们分别使两种上皮细胞系的CCL20分泌大幅增加以及使树突状细胞和朗格汉斯细胞成熟。